Guided Therapeutics GTHP

OTC GTHP
$0.19 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Guided Therapeutics (GTHP) stock price is $0.19, unchanged on the day, as of Oct 15, 2026. It has a market cap of $22.38Mn, and is classified in the Medical Devices industry (Healthcare sector).

Key Stats
Market Cap22.38 Mn
P/E-6.14
P/S34.43
Div. Yield0.00
Total Debt (Qtr)354,000.00
Add ratio to table…

About

Guided Therapeutics, Inc. is a medical technology company focused on developing innovative medical devices that improve healthcare. Its primary product is the LuViva Advanced Cervical Scan, a noninvasive cervical cancer detection device that uses biophotonics to scan the cervix with light and analyze reflected and fluorescent light. The device is designed to identify cervical cancers and precancers painlessly and at the point of care, offering a rapid alternative to…

Read more ↓
Sector: Healthcare Sector rationale The company designs and manufactures the LuViva Advanced Cervical Scan, a medical device used for cervical cancer detection, and sells single-use disposable cervical guides. Its revenue is derived from selling these medical products to distributors, hospitals, and government health programs, which falls squarely within the Medical Devices industry of the Healthcare sector. Industries: Medical Devices Medical Devices Primary Guided Therapeutics designs and manufactures the LuViva Advanced Cervical Scan, a medical device used for the noninvasive detection of cervical cancer. The company generates revenue from the sale of these therapeutic/diagnostic systems to distributors and government health programs. Medical Supplies Medical Supplies Secondary The company sells single-use disposable cervical guides that accompany the LuViva systems, which are medical consumables/supplies. Classified using BQ-MICS CIK: 0000924515

Product and Service Breakdown of Revenue (2020)

History

Statement Geographical Breakdown of Revenue (2020)

History
Peer percentiles

How Guided Therapeutics ranks

Ranked against the 248 companies in Medical Devices and Diagnostics58 metrics · as of Oct 16, 2026

Valuation

12 metrics · Lower multiples rank higher; a negative multiple ranks last
  • P/ENegative earnings −5.03xMedian 28.9x 39th
  • P/FCFNegative free cash flow −12.2xMedian 26.0x 42nd
  • P/Operating cash flowNegative operating cash flow −12.2xMedian 20.1x 41st
  • P/S 28.2xMedian 3.07x 9th
  • P/BNegative shareholder equity −3.18xMedian 2.40x Not meaningful —
  • P/Tangible bookNegative tangible equity −3.18xMedian 3.05x Not meaningful —
  • EV/EBITDANegative EBITDA −10.6xMedian 18.0x 35th
  • EV/EBITNegative EBIT −9.46xMedian 27.8x 39th
  • EV/Revenue 28.7xMedian 3.25x 7th
  • EV/FCFNegative free cash flow −12.4xMedian 26.6x 35th
  • EV/Operating cash flowNegative operating cash flow −12.4xMedian 21.9x 33rd
  • PEG (3Y EPS CAGR)Negative earnings −0.17Median 0.86 Not meaningful —
Peer group

Peer Comparison

Companies in the Medical Devices
View all peers
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 TMO Thermo Fisher Scientific Inc. 260.02 Bn37.325.6142.55 Bn
2 ABT Abbott Laboratories 171.42 Bn31.603.6832.61 Bn
3 DHR Danaher Corp /De/ 164.29 Bn41.036.5426.56 Bn
4 ISRG Intuitive Surgical Inc 152.45 Bn48.5713.82-
5 MDT Medtronic plc 119.48 Bn22.843.1828.15 Bn
6 SYK Stryker Corp 112.93 Bn30.284.3714.94 Bn
7 BSX Boston Scientific Corp 64.82 Bn17.643.0912.62 Bn
8 GTHP Guided Therapeutics Inc 0.02 Bn-6.1434.430.00 Bn